I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists.
Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Performance of [18F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis
Published in: Diagnostics
BACKGROUND: Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([ 18F]FDG PET/CT) has been suggested as a useful imaging method for diagnosing cyst infections in patients with autosomal dominant polycystic kidney disease (ADPKD). The aim of this article is to provide evidence-based data in this setting. METHODS: A systematic literature review (exploring several bibliographic databases) and a bivariate meta-analysis were carried out to calculate the pooled diagnostic performance of [ 18F]FDG PET/CT in diagnosing probable cyst infection in ADPKD. RESULTS: Ten studies (282 PET/CT scans and 249 patients) were included...
Nuclear medicine practice for the assessment of cardiac sarcoidosis and amyloidosis: A survey endorsed by the EANM and EACVI
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Irene Gotuzzo,
Riemer H J A Slart, Alessia Gimelli, Nabila Ashri, Constantinos Anagnostopoulos, Jan Bucerius, Ronny R Buechel, Oliver Gaemperli, Olivier Gheysens,
Andor W J M Glaudemans, Gilbert Habib, Fabian Hyafil, Mark Lubberink, Antti Saraste, Tomaz Podlesnikar, Marc R Dweck, Paola A Erba
Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance
Published in: European Journal of Nuclear Medicine and Molecular Imaging
PURPOSE: Consensus on the choice of the most accurate imaging strategy in diabetic foot infective and non-infective complications is still lacking. This document provides evidence-based recommendations, aiming at defining which imaging modality should be preferred in different clinical settings. METHODS: This working group includes 8 nuclear medicine physicians appointed by the European Association of Nuclear Medicine (EANM), 3 radiologists and 3 clinicians (one diabetologist, one podiatrist and one infectious diseases specialist) selected for their expertise in diabetic foot. The latter members formulated some clinical questions that are not...
Chiara Lauri, Edel Noriega-Álvarez, Riddhika M Chakravartty, Olivier Gheysens,
Andor W J M Glaudemans,
Riemer H J A Slart,
Thomas C Kwee, Frédéric Lecouvet, Emmanouil Panagiotidis, Jules Zhang-Yin, Jose Luis Lazaro Martinez, Benjamin A Lipsky, Luigi Uccioli,
Alberto Signore
Multimodality imaging to assess diagnosis and evaluate complications of large vessel arteritis
Published in: Journal of Nuclear Cardiology
Different types of vasculitis can be distinguished according to the blood vessel’s size that is preferentially affected: large-vessel, medium-vessel, and small-vessel vasculitides. Giant cell arteritis (GCA) and Takayasu’s arteritis (TAK) are the main forms of large-vessel vasculitis, and may lead to lumen narrowing. Clinical manifestations of arterial narrowing on the short- and long term include vision loss, stroke, limb ischaemia and heart failure. Imaging tools are well established diagnostic tests for large-vessel vasculitis and may aid therapy monitoring in selected cases, while providing important information regarding the occurrence...
Heliyon medical imaging: Shaping the future of health
Published in: Heliyon